SCHEDULE 13D/A: LiqTech International Extends Debt Maturity and Amends Warrants with Major Shareholder
Schedule 13D Amendment
LiqTech International, Inc. has announced an agreement with its significant shareholder, Bleichroeder LP, to extend the maturity of certain Notes to May 2027 and amend existing warrants, adjusting their exercise price and expiration.
Summary
- LiqTech International, Inc. and funds managed by Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach agreed to extend the maturity date of certain Notes.
- The Notes' maturity date was extended from January 1, 2026, to May 1, 2027.
- Interest on these Notes will commence on January 1, 2026, at a rate of 10% per annum, payable in cash or Common Stock at the Issuer's election.
- As consideration for this extension, warrants issued on June 22, 2022, to purchase an aggregate of 531,250 shares of Common Stock were amended.
- The exercise price of these 2022 Warrants was reduced from $5.20 per share to $2.00 per share.
- The expiration date of these 2022 Warrants was extended from June 22, 2027, to December 31, 2029.
- Resale registration rights for shares issuable upon conversion of these amended warrants were confirmed.
- The reporting persons (Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach) collectively beneficially own 3,182,239 shares, representing 33.7% of LiqTech International, Inc.'s Common Stock.
Sentiment
Score: 6
Explanation: The extension of debt maturity provides LiqTech International, Inc. with more time and financial flexibility, which is generally positive for stability. However, this comes at the cost of a higher interest rate and more favorable warrant terms for the reporting persons, which could lead to increased dilution for other shareholders, resulting in a mixed but slightly positive outlook for the company's immediate financial stability.
Positives
- For LiqTech International, Inc., the maturity of the Notes was extended from January 1, 2026, to May 1, 2027, providing additional financial flexibility and liquidity management time.
- For the reporting persons (Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach), the exercise price of the 2022 Warrants was significantly reduced from $5.20 to $2.00 per share, increasing their potential upside.
- For the reporting persons, the expiration date of the 2022 Warrants was extended from June 22, 2027, to December 31, 2029, providing a longer period to exercise the warrants.
Negatives
- For LiqTech International, Inc., the exercise price of the 2022 Warrants was reduced from $5.20 to $2.00 per share, which could lead to greater dilution for existing shareholders if the warrants are exercised.
- For LiqTech International, Inc., interest on the Notes will commence at 10% per annum from January 1, 2026, representing a new or increased financial obligation that can be paid in cash or Common Stock.
- For the reporting persons, the repayment of the Notes is delayed from January 1, 2026, to May 1, 2027.
Risks
- Potential dilution for existing shareholders if LiqTech International, Inc. elects to pay interest on the Notes in Common Stock.
- Potential dilution for existing shareholders from the exercise of the amended 2022 Warrants, especially with the reduced exercise price of $2.00 per share.
- Increased interest expense for LiqTech International, Inc. starting January 1, 2026, at 10% per annum.
Future Outlook
The agreement provides LiqTech International, Inc. with an extended period to repay its Notes, pushing the maturity to May 1, 2027. It also sets a future obligation for 10% annual interest payments on these Notes starting January 1, 2026, with the flexibility for the Issuer to pay in cash or Common Stock. The amended warrants, with a lower exercise price and extended term, represent a potential future source of equity capital or dilution, depending on the company's stock performance and the warrant holders' decisions.
Industry Context
This filing reflects a specific financial restructuring between a company and a significant investor, common in industries where companies may seek to optimize their capital structure or gain more operational runway. It does not provide sufficient information to analyze broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Potential dilution from the issuance of Common Stock for interest payments and from the exercise of the amended 2022 Warrants due to the reduced exercise price.
- Creditors (Reporting Persons): Delayed repayment of Notes but compensated with a higher interest rate and more favorable warrant terms.
Next Steps
- LiqTech International, Inc. will begin paying 10% annual interest on the Notes starting January 1, 2026.
- The Notes will mature on May 1, 2027.
- The amended 2022 Warrants will remain exercisable until December 31, 2029.
Key Dates
| Date | Description |
|---|---|
| 2022-06-22 | Original issuance date of 2022 Warrants. |
| 2024-11-19 | Original Schedule 13D filing date by Reporting Persons. |
| 2025-01-01 | Original maturity date of the Notes. |
| 2025-03-21 | Amendment No. 1 to Schedule 13D filed. |
| 2025-03-26 | Date of agreement between Issuer and Reporting Persons for the 2025 Extension of Notes and amendment of Warrants. |
| 2025-03-28 | Filing date of this Amendment No. 2 to Schedule 13D. |
| 2026-01-01 | Commencement date for 10% per annum interest payments on the Notes. |
| 2027-05-01 | New maturity date of the Notes (extended from January 1, 2026). |
| 2027-06-22 | Original expiration date of the 2022 Warrants. |
| 2029-12-31 | New expiration date of the 2022 Warrants (extended from June 22, 2027). |
Keywords
LiqTech International, SEC filing, Schedule 13D, debt extension, warrant amendment, equity dilution, corporate finance, investment, shareholder agreement, financial restructuring
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.